Uncategorised - European Medical Journal

AI visualization predicting facial aging from tobacco use

AI Model Predicts Facial Aging from Tobacco Use

A new AI-based simulator integrating dermatologist expertise predicts how tobacco use accelerates facial aging over 15 years.

Pieter Sonneveld

Hema Now: Episode 28: Charting a New Era in Myeloma Care

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

facilitated telemedicine

Facilitated Telemedicine Boosts Healthcare Access

A randomised controlled trial examined the effectiveness of facilitated telemedicine for hepatitis C virus treatments.

stroke

Stroke Risk in Women: Insights from 30-Year Study

Research shows inflammation and cholesterol levels increase long-term stroke risk in healthy women.

brain aneurysm

ROAR-DNA Study Targets Brain Aneurysm Risk

ROAR-DNA merges genetics and clinical data to predict, prevent, and personalize treatment for brain aneurysms.

Artificial Intelligence Predicts Treatment Success in Psoriatic and Axial Spondyloarthritis

Artificial Intelligence Predicts Treatment Success in Psoriatic and Axial Spondyloarthritis

Machine learning models accurately predict which psoriatic and axial spondyloarthritis patients will respond to treatment, paving the way for personalised therapy decisions.

patient exercise monitoring

CHEST 2025: Improved Cardiac Function with Treprostinil in ASCENT Trial

Inhaled treprostinil treatment improved cardiac effort and physiological function in patients with pulmonary hypertension–interstitial lung disease.

Linked Colour Imaging Reduces Missed Polyps in Colonoscopy

Linked Colour Imaging Reduces Missed Polyps in Colonoscopy

A Japanese multicentre study finds linked colour imaging significantly reduces missed colorectal polyps compared with standard white light imaging, improving adenoma detection rates.

liver

Older Age, Not Comorbidity, Drives Poorer Survival in Liver Cancer

A new study has found that it is older age hat is most strongly linked to poorer survival outcomes in liver cancer.

Long-Term Smell Loss Common After COVID-19

A USA cohort study finds persistent olfactory dysfunction up to 2 years after COVID-19, even in people unaware of smell loss.